FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37890311000001103: Xospata 40mg tablets (Astellas Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
539161000001118 Xospata 40mg tablets (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
539171000001111 Xospata 40mg tablets (Astellas Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xospata 40mg tablets (Astellas Pharma Ltd) Has specific active ingredient Gilteritinib fumarate true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Is a Gilteritinib 40mg tablets true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Is a Xospata true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Gilteritinib false Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has specific active ingredient Gilteritinib fumarate false Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Xospata 40mg tablets (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Gilteritinib false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xospata 40mg tablets (Astellas Pharma Ltd) 84 tablet 4 x 21 tablets Has AMP True Xospata 40mg tablets (Astellas Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start